Wormwood

Artemisia absinthium has traditionally been used to treat parasitic, and bacterial infection, as well as neurodegenerative disorders, cancer, stomach aches, fevers, declining cognitive function, hepatitis, and as a cardiac stimulant, nootropic, and antispasmodic agent ^{30,17Reference 30Ghafoori et al. · 2014Study of effect of extraction conditions on the biochemical composition and antioxidant activity of Artemisia absinthium by HPLC and TLCReference 17Joshi · 2013In vitroVolatile composition and antimicrobial activity of the essential oil of Artemisia absinthium growing in the Western Ghats region of North West Karnataka, India — in vitroView study →}. Artemesia as a genus, including wormwood, were often used to treat conditions such as malaria, hepatitis, cancer, inflammation, and fungal infections ^{30,33Reference 30Ghafoori et al. · 2014Study of effect of extraction conditions on the biochemical composition and antioxidant activity of Artemisia absinthium by HPLC and TLCReference 33Bora et al. · 2011ReviewThe genus Artemisia: a comprehensive review}.

In Culpeper’s complete herbal, Culpepper lists wormwood seeds for expelling worms ^{35Reference 35Culpeper · 1995Culpeper’s complete herbal: A book of natural remedies for ancient ills}.

In traditional Chinese medicine, this herb is referred to as yin chen and is used to treat acute biliary dysentery, cancers, and neurodegenerative diseases ^{17,36Reference 17Joshi · 2013In vitroVolatile composition and antimicrobial activity of the essential oil of Artemisia absinthium growing in the Western Ghats region of North West Karnataka, India — in vitroView study →Reference 36Yang et al. · 2013Introduction to Chinese materia medica (3rd ed.). (Pg 217-220)}. (Note: in standard TCM, Yin Chen (Yin Chen Hao) usually denotes Artemisia capillaris / A. scoparia rather than A. absinthium — the names are often conflated.)

Pinyin

Yin Chen (Alternate names are Yin Chen Hao or Mian yin chen)

Taste

Bitter and pungent ^{36Reference 36Yang et al. · 2013Introduction to Chinese materia medica (3rd ed.). (Pg 217-220)}

Energy

Cool ^{36Reference 36Yang et al. · 2013Introduction to Chinese materia medica (3rd ed.). (Pg 217-220)}

Actions

Clears heat, drains dampness, promotes gallbladder function, relieves jaundice ^{36Reference 36Yang et al. · 2013Introduction to Chinese materia medica (3rd ed.). (Pg 217-220)}.

Indications

Jaundice, scanty urine, eczema, itching, abdominal distention and fullness, greasy tongue coating ^{36Reference 36Yang et al. · 2013Introduction to Chinese materia medica (3rd ed.). (Pg 217-220)}.

In northern parts of Iran, where Artemisia absinthium grows wild, its aerial parts are traditionally used as both food and medicine ^{30Reference 30Ghafoori et al. · 2014Study of effect of extraction conditions on the biochemical composition and antioxidant activity of Artemisia absinthium by HPLC and TLC}. It has been, and is continued to be used in the food industry to prepare aperitifs, bitters, and spirits ^{17Reference 17Joshi · 2013In vitroVolatile composition and antimicrobial activity of the essential oil of Artemisia absinthium growing in the Western Ghats region of North West Karnataka, India — in vitroView study →}, such as absinth.

This is wormwood’s strongest human signal. In a double-blind, placebo-controlled, multicentre study in Germany (n=40 Crohn’s patients), a herbal blend delivering dried wormwood (3×500 mg/day) alongside a tapering steroid dose produced steady clinical improvement in 90% of the wormwood group as steroids were withdrawn, versus worsening in the placebo group ^{1Reference 1Omer et al. · 2007RCTSteroid-sparing effect of wormwood (Artemisia absinthium) in Crohn’s disease: a double-blind placebo-controlled study — randomised placebo-controlled trialView study →}. A second controlled trial (n=20) using dried powdered wormwood (3×750 mg/day for 6 weeks) found average serum TNF-α fell from ~24.5 to ~8.0 pg/mL with remission (CDAI improvement) in 8 of 10 treated patients versus 2 of 10 controls ^{2Reference 2Krebs et al. · 2010Clinical trialWormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn’s disease — controlled clinical trialView study →}. The mechanism is plausible and consistent — TNF-α is central to Crohn’s, and wormwood extracts suppress it — but both trials are small, from overlapping investigators, and used dried whole herb rather than any standardised extract. Systematic reviews and a meta-analysis of herbal therapy in IBD include these results while cautioning that the evidence base remains limited ^{27Reference 27Rahimi et al. · 2013Meta-analysisInduction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: a meta-analysisView study →}.

Gap: No large, independent, adequately powered replication; the positive trials are small and share investigators, and durability beyond a few weeks is untested.

Wormwood is one of the classic intensely bitter herbs, and its digestive use is the best-documented traditional indication. The bitter sesquiterpene lactone absinthin activates bitter (TAS2R) taste receptors, which reflexively stimulate salivary, gastric and biliary secretion — the rationale for its use in loss of appetite and dyspeptic complaints. This indication is anchored by pharmacopoeial monographs (German Commission E and the EMA/HMPC herbal monograph) that classify Absinthii herba for appetite loss and dyspeptic/biliary complaints ^{13,14Reference 13Blumenthal et al. · 1998ReviewThe Complete German Commission E Monographs — Wormwood (Absinthii herba): appetite loss, dyspeptic and biliary complaints — pharmacopoeial monographReference 14European Medicines Agency · 2009ReviewCommunity herbal monograph on Artemisia absinthium L., herba — pharmacopoeial monographView study →}, rather than by modern trials. A small controlled study of a multi-herb bitter preparation containing wormwood reported relief of functional upper-abdominal symptoms, but the effect cannot be attributed to wormwood alone ^{28Reference 28Westphal et al. · 1996RCTPhytotherapy in functional upper abdominal complaints: results of a clinical study with a preparation of several plants (inclView study →}.

Gap: Almost no modern monotherapy trials; the human evidence is pharmacopoeial and traditional, and the one supportive clinical study used a multi-herb formula.

Rodent models are consistent. An aqueous extract protected mouse liver against chemically and immunologically induced injury ^{5Reference 5Amat et al. · 2010AnimalIn vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice — animal modelView study →}, and an aqueous extract reversed carbon-tetrachloride–induced hepatic damage in rats, normalising raised transaminases and lipid peroxidation ^{6Reference 6Saxena et al. · 2012AnimalReversal of carbon tetrachloride-induced hepatic injury by aqueous extract of Artemisia absinthium in Sprague-Dawley rats — animal modelView study →}. A 2026 mouse study went further mechanistically: a methanol extract (400 mg/kg) attenuated CCl₄-induced liver fibrosis by suppressing hepatic stellate-cell activation and downregulating TGF-β/PDGF-D and fibrotic markers (COL1A1, αSMA) via TGF-β/SMAD, NF-κB and MAPK pathways, with a benefit comparable to silymarin ^{7Reference 7Manzoor et al. · 2026AnimalArtemisia absinthium attenuates hepatic fibrosis in mice by suppressing hepatic stellate cell activation and modulating inflammatory chemokine signalling — animal modelView study →}. The traditional Chinese and Persian use of the herb for jaundice and hepatitis aligns with this direction.

Gap: Entirely preclinical — no human hepatoprotection trials, and doses used in rodents (hundreds of mg/kg) do not map onto documented human dosing.

Wormwood extracts are reliably active in cell-free antioxidant assays (DPPH, FRAP, hydroxyl- and NO-radical scavenging), an activity attributed to flavonol glycosides of quercetin and isorhamnetin plus phenolic acids ^{8,10Reference 8Țicolea et al. · 2025In vitroFlowers and leaves of Artemisia absinthium and Artemisia annua: phytochemical characterization, anti-inflammatory, antioxidant and anti-proliferative activities — in vitro and rat modelView study →Reference 10Batiha et al. · 2020ReviewBioactive compounds, pharmacological actions, and pharmacokinetics of wormwood (Artemisia absinthium) — reviewView study →}. A 2025 study characterised flowers and leaves and found rich polyphenol content with moderate in vitro antioxidant activity, and confirmed in vivo shifts in oxidative-status markers in a rat inflammation model ^{8Reference 8Țicolea et al. · 2025In vitroFlowers and leaves of Artemisia absinthium and Artemisia annua: phytochemical characterization, anti-inflammatory, antioxidant and anti-proliferative activities — in vitro and rat modelView study →}. The activity is real but preparation-dependent — methanolic and ethanolic extracts outperform water extracts, and content varies with chemotype and plant organ.

Gap: No human antioxidant-endpoint data; “antioxidant” here is a laboratory property, not a demonstrated clinical benefit, and potency is described as moderate.

The essential oil shows in vitro antibacterial and antifungal activity, most pronounced against gram-positive bacteria — gram-negative species are relatively protected by their hydrophilic outer membrane, which blocks the oil’s lipophilic terpenoids ^{17Reference 17Joshi · 2013In vitroVolatile composition and antimicrobial activity of the essential oil of Artemisia absinthium growing in the Western Ghats region of North West Karnataka, India — in vitroView study →}. Broader Artemisia essential-oil screening confirms activity that tracks with oil composition, including 1,8-cineole and other monoterpenes ^{18Reference 18Lopes-Lutz et al. · 2008In vitroScreening of chemical composition, antimicrobial and antioxidant activities of Artemisia essential oils — in vitroView study →}. Activity is a property of the volatile oil, not the water-based preparations used in the Crohn’s trials.

Gap: In vitro only, with the effect residing in the essential oil rather than the herb as commonly used; no clinical infection data.

This extends wormwood’s namesake traditional use (“worm-wood”). In vitro work found that A. absinthium extract inhibited embryogenesis and egg hatching of the roundworm Ascaris suum ^{19Reference 19Băieş et al. · 2022In vitroThe effects of Allium sativum, Artemisia absinthium, Cucurbita pepo, Coriandrum sativum, Satureja hortensis and Calendula officinalis on the embryogenesis of Ascaris suum eggs — in vitroView study →}, and a rat study compared A. absinthium against Trichinella spiralis infection ^{20Reference 20Caner et al. · 2008AnimalComparison of the effects of Artemisia vulgaris and Artemisia absinthium growing in western Anatolia against trichinellosis (Trichinella spiralis) in rats — animal modelView study →}. Extracts also show strong larvicidal activity against mosquito vectors ^{21Reference 21Ali et al. · 2018In vitroChicory (Cichorium intybus) and wormwood (Artemisia absinthium) extracts exhibit strong larvicidal activity against mosquito vectors of malaria, dengue fever and filariasis — in vitroView study →} and, formulated as an essential-oil nanocochleate, antileishmanial activity in vitro and in vivo ^{22Reference 22Tamargo et al. · 2017In vitroIn vitro and in vivo evaluation of essential oil from Artemisia absinthium L. formulated in nanocochleates against cutaneous leishmaniasis — animal modelView study →}. The signal is broad across parasite types but preparation-varied and untested in humans for helminth clearance.

Gap: No human anthelmintic efficacy or safety trials; evidence is in vitro/animal and spread across many different parasite species and formulations.

The traditional nootropic claim has partial mechanistic support and a large asterisk. In a rat model, hydroalcoholic extract improved scopolamine-impaired learning and memory (Morris water maze, passive avoidance) and reduced brain oxidative damage while raising SOD and catalase ^{9Reference 9Rahimi et al. · 2023AnimalThe effects of Artemisia absinthium L. on scopolamine-induced learning and memory impairment and brain tissue oxidative damage in adult rats — animal modelView study →}. Extract also protected OLN-93 glial cells against quinolinic-acid neurotoxicity in vitro ^{12Reference 12Rashidi et al. · 2023In vitroArtemisia absinthium extract attenuates quinolinic acid-induced cell injury in OLN-93 cells — in vitroView study →}, and older work found wormwood displaced ligand at CNS nicotinic acetylcholine receptors, a target relevant to failing memory ^{23Reference 23Wake et al. · 2000In vitroCNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory — in vitroView study →}. The asterisk: the same plant contains thujone, a GABA-A receptor antagonist and dose-dependent convulsant ^{15Reference 15Höld et al. · 2000Höld, K. M., Sirisoma, N. S., Ikeda, T., Narahashi, T., & Casida, J. E. (2000). α-Thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proceedings of the National Academy of Sciences USA. https://pubmed.ncbi.nlm.nih.gov/10725394/View study →}, so any “neuroactive” reading must be weighed against neurotoxic risk at higher exposures.

Gap: Rodent and cell-line only, mechanistically mixed (protective flavonoids vs. neurotoxic thujone), and no human cognitive data.

Evidence is early. Extracts inhibit α-amylase and other carbohydrate-handling enzymes in vitro ^{24Reference 24Fostok et al. · 2026In vitroNatural α-amylase inhibitors from medicinal herbs: in vitro evaluation of extracts prepared with food-compatible solvents — in vitroView study →}, and an ethanolic extract improved oxidative-stress and apoptosis markers in the kidneys of streptozotocin-induced diabetic rats ^{11Reference 11Bagheri et al. · 2020AnimalEffect of Artemisia absinthium ethanolic extract on oxidative stress markers and TLR4, S100A4, Bax and Bcl-2 gene expression in the kidney of STZ-induced diabetic rats — animal modelView study →}. Comparative in vitro work also reports antidiabetic and anti-inflammatory potential for membrane-processed extracts ^{29Reference 29Neagu et al. · 2023In vitroIn vitro assessment of the antidiabetic and anti-inflammatory potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum extracts processed using membrane technologies — in vitroView study →}. There is no human glucose-lowering trial for wormwood specifically.

Gap: In vitro and single-model rodent data only; no clinical glycaemic endpoints.

Wormwood extracts trigger apoptosis in cultured cancer cells — reported via multiple apoptotic pathways in human breast cancer lines ^{25Reference 25Shafi et al. · 2012In vitroArtemisia absinthium (AA): a novel potential complementary and alternative medicine for breast cancer — in vitroView study →} and, for the constituent thujone, metabolic disruption of placental choriocarcinoma cells ^{26Reference 26Lee et al. · 2020In vitroLee, J. Y., et al. (2020). α,β-Thujone suppresses human placental choriocarcinoma cells via metabolic disruption — in vitro. Reproduction. https://pubmed.ncbi.nlm.nih.gov/32240978/View study →}. A 2025 study also showed antiproliferative activity against ovarian tumour lines linked to apoptosis and multidrug-resistance modulation ^{8Reference 8Țicolea et al. · 2025In vitroFlowers and leaves of Artemisia absinthium and Artemisia annua: phytochemical characterization, anti-inflammatory, antioxidant and anti-proliferative activities — in vitro and rat modelView study →}. All of this is cell-line work: there is no in vivo tumour-model efficacy or human oncology data, and cytotoxicity in a dish is a weak predictor of clinical benefit.

Gap: Confined to cell lines; no animal efficacy or human trials, and apoptotic activity in vitro does not establish anticancer use.

Wormwood’s principal hazard is thujone, a monoterpene ketone in its essential oil that acts as a GABA-A receptor antagonist and a dose-dependent convulsant, producing tonic-clonic seizures in animals above threshold and neuro-excitatory poisoning (agitation, insomnia, hallucinations) in humans after heavy or prolonged ingestion ^{15,16Reference 15Höld et al. · 2000Höld, K. M., Sirisoma, N. S., Ikeda, T., Narahashi, T., & Casida, J. E. (2000). α-Thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proceedings of the National Academy of Sciences USA. https://pubmed.ncbi.nlm.nih.gov/10725394/View study →Reference 16Lachenmeier · 2010ReviewWormwood (Artemisia absinthium L.) — a curious plant with both neurotoxic and neuroprotective properties? — review/commentaryView study →}. For this reason use should be short-term (traditionally under 2–4 weeks), and the neurotoxic risk is concentrated in the essential oil and high-thujone chemotypes rather than in dried-herb bitters or the thujone-free extracts used in the Crohn’s and IgA-nephropathy trials ^{2,3Reference 2Krebs et al. · 2010Clinical trialWormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn’s disease — controlled clinical trialView study →Reference 3Krebs et al. · 2010Clinical trialWormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled clinical trialView study →}. As an Asteraceae (daisy family) member, wormwood can provoke allergic/contact reactions in people sensitised to that family, and it is a documented bitter that stimulates gastric and biliary secretion, so caution applies in active gastric or duodenal ulceration and in biliary obstruction. Thujone content is capped in food and beverages by EU regulation, and the herb should not be used in pregnancy (see below).

Interactions and CYP450: not assessed. No human drug-interaction trial has been identified for wormwood. Thujone is metabolised by liver CYP enzymes (including CYP3A4) to 7-hydroxythujone ^{15Reference 15Höld et al. · 2000Höld, K. M., Sirisoma, N. S., Ikeda, T., Narahashi, T., & Casida, J. E. (2000). α-Thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proceedings of the National Academy of Sciences USA. https://pubmed.ncbi.nlm.nih.gov/10725394/View study →}, but this is a metabolic route, not a demonstrated clinical interaction — do not read it as an interaction profile.